Cost-effectiveness analysis of spinal cord stimulation in treatment of failed back surgery syndrome

Journal of Pain and Symptom Management
G K BellR B North

Abstract

This article presents an analysis of the medical costs of spinal cord stimulation (SCS) therapy in the treatment of patients with failed back surgery syndrome (FBSS). We compared the medical costs of SCS therapy with an alternative regimen of surgeries and other interventions. Externally powered (external) and fully internalized (internal) SCS systems were considered separately. Clinical management models of each of the therapy alternatives were derived from the clinical literature, retrospective data sets, expert opinion, and published diagnostic and therapy protocols. No value was placed on pain relief or improvements in the quality of life that successful SCS therapy can generate. We found that by reducing the demand for medical care by FBSS patients, SCS therapy can lower medical costs. On average, given current screening and efficacy rates, SCS therapy pays for itself within 5.5 years. For those patients for whom SCS therapy is clinically efficacious, the therapy pays for itself within 2.1 years.

References

Sep 1, 1991·The Clinical Journal of Pain·J J Pinsky
Jan 1, 1991·Annual Review of Public Health·R A DeyoE Volinn
Oct 3, 1991·The New England Journal of Medicine·R A Deyo
Jan 1, 1991·Acta neurochirurgica. Supplementum·S Bel, B L Bauer
Nov 24, 1989·JAMA : the Journal of the American Medical Association·J M Eisenberg
Jul 1, 1988·Journal of Neurosurgery·D M LongN H Hendler
Jan 1, 1986·International Journal of Law and Psychiatry·M Kärrström
Nov 1, 1993·Neurosurgery·E Van de Kelft, C De La Porte

❮ Previous
Next ❯

Citations

Oct 26, 2001·Current Pain and Headache Reports·T R Deer
Sep 18, 1997·Journal of Pain and Symptom Management·E S Krames, K Olson
Sep 18, 1997·Journal of Pain and Symptom Management·S J HassenbuschG K Bell
Jan 1, 2000·Neuromodulation : Journal of the International Neuromodulation Society·V HeideckeW Burkert
Aug 1, 2000·Neuromodulation : Journal of the International Neuromodulation Society·K D Willis, P S Staats
Jan 1, 2001·Neuromodulation : Journal of the International Neuromodulation Society·Jean-Christophe LevequeJohn P Gorecki
Apr 1, 2001·Neuromodulation : Journal of the International Neuromodulation Society·G BarolatA Sharan
Apr 1, 2002·Neuromodulation : Journal of the International Neuromodulation Society·Keith Budd
Jul 1, 2002·Neuromodulation : Journal of the International Neuromodulation Society·Ashwini SharanGiancarlo Barolat
Jan 1, 2003·Neuromodulation : Journal of the International Neuromodulation Society·Martin E WeinandMiguel Melgar
Jan 5, 2000·The Clinical Journal of Pain·D C Turk
Oct 27, 2004·The Clinical Journal of Pain·Nagy A MekhailMichael Stanton-Hicks
Jul 1, 1998·Neuromodulation : Journal of the International Neuromodulation Society·K M Alo
Jan 1, 1998·Neuromodulation : Journal of the International Neuromodulation Society·K M AloV Redko
Jan 1, 2004·Neuromodulation : Journal of the International Neuromodulation Society·Richard B NorthRod Taylor
Jan 1, 2004·Neuromodulation : Journal of the International Neuromodulation Society·Y Eugene MironerSteve Grumman
Oct 1, 2008·Neuromodulation : Journal of the International Neuromodulation Society·Samira Akmal, M Sam Eljamel
Jan 1, 2010·Neuromodulation : Journal of the International Neuromodulation Society·Joshua Prager
Oct 14, 2011·Neuromodulation : Journal of the International Neuromodulation Society·Shivanand P LadJaimie M Henderson
Oct 14, 2011·Neuromodulation : Journal of the International Neuromodulation Society·Robert M Levy
Oct 14, 2011·Neuromodulation : Journal of the International Neuromodulation Society·Elliot S KramesRobert Levy
Oct 27, 2011·Neuromodulation : Journal of the International Neuromodulation Society·Y Eugene MironerPhillip C LaTourette
Nov 20, 1998·BMJ : British Medical Journal·T J NurmikkoJ R Wiles
Feb 13, 2001·Anesthesia and Analgesia·P F WhiteJ W Chiu
Oct 26, 2007·Anesthesia and Analgesia·María Luisa García-PérezFrancisco Javier Belda
Sep 12, 2006·Journal of Neurosurgery. Spine·Joshua M RosenowJaimie M Henderson
Sep 12, 2006·Journal of Neurosurgery. Spine·Krishna KumarShivani Gupta
Dec 12, 2012·Surgical Neurology International·Claudio YampolskyDamián Bendersky
Jun 3, 2014·Neurosurgical Focus·Matthew D AlvinThomas E Mroz
Mar 14, 2013·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Scott GuillemetteJoshua P Prager
Mar 5, 2004·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Timothy DeerKim Burchiel
Apr 22, 2004·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Curtis W SlipmanEdward J Vresilovic
Oct 28, 2010·Physical Medicine and Rehabilitation Clinics of North America·David Bagnall
Dec 14, 2011·Neurosurgery·Nestor D TomyczMichael Y Oh
Nov 1, 2006·The Journal of Pain : Official Journal of the American Pain Society·Robert J Gatchel, Akiko Okifuji
Dec 14, 2006·Pain Practice : the Official Journal of World Institute of Pain·Guy R FogelOctavio Calvillo
Feb 28, 2013·Neuromodulation : Journal of the International Neuromodulation Society·Lawrence PoreeLouise Schultz
Jun 7, 2013·Neuromodulation : Journal of the International Neuromodulation Society·Dirk De RidderSven Vanneste

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.